June 16, 2022
(press release)
–
The revenue from injectables in 2021 was US$ 33.8 Bn and is expected to grow above 5X during the forecast period.
* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.